Alexander O. Schuth, M.D.

Chief Operating and Financial Officer and SecretaryatDenali Therapeutics· In proxies 2021–2025

Pay in FY2025+6% from the year before · Denali Therapeutics stock -19.0% the same year

Alexander O. Schuth, M.D. was paid $4.3M in FY2025 (Dec), up 6%. Denali Therapeutics stock fell 19.0% that year.

Pay$100 in the stock at the end of FY20 → $20

Pay is from the Summary Compensation Table of each Denali Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

DNLI
Denali TherapeuticsPublic company · 5 yr
- Chief Operating and Financial Officer and Secretary2021 – Present · 5 yrStock in role -78%

Roles come from the proxy statements of each company.

Activity

Pay
Denali Therapeutics Chief Operating and Financial Officer and Secretary pay fell 27% to $4.2M. The stock fell 23% in FY2023 (Dec).
DEF 14AApr 18, 2024
Pay
Denali Therapeutics Chief Operating and Financial Officer and Secretary pay fell 13% to $5.7M. The stock fell 38% in FY2022 (Dec).
DEF 14AApr 18, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?